How to buy ResApp Health shares

Own ResApp Health shares in just a few minutes.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

ResApp Health Limited is a health information services business based in Australia. ResApp Health shares (RAP) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. ResApp Health has a trailing 12-month revenue of around $46,197. If you're looking to buy shares, check out the steps below.

How to buy shares in ResApp Health

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for ResApp Health. Find the share by name or ticker symbol: RAP. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until ResApp Health reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of ResApp Health. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

ResApp Health share price

Use our graph to track the performance of RAP stocks over time.

ResApp Health shares at a glance

Information last updated 2021-06-18.
52-week range$0.046 - $0.19
50-day moving average $0.0512
200-day moving average $0.0667
Target price$0.24
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.008

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Markets
Superhero share trading
AUD $5
No
ASX shares, ETFs
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
Bell Direct Share Trading
Finder AwardExclusive
Bell Direct Share Trading
AUD $15
No
ASX shares, mFunds, ETFs
⭐ Finder Exclusive: Get 5 free stock trades and unlimited ETF trades until July 31, 2021 when you join Bell Direct.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
IG Share Trading
Finder Award
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
AUD $6.99
No
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
AUD $11 or 0.1%
No
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
loading

Compare up to 4 providers

Is it a good time to buy ResApp Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

ResApp Health price performance over time

Historical closes compared with the last close of A$0.051

1 week (2021-06-18) 10.87%
1 month (2021-05-25) -8.93%
3 months (2021-03-25) -29.17%
6 months (2020-12-24) -36.25%
1 year (2020-06-25) -70.86%
2 years (2019-06-25) -72.43%
3 years (2018-06-25) -60.77%
5 years (2016-06-24) -84.55%

ResApp Health financials

Revenue TTM $46,197
Gross profit TTM $1 million
Return on assets TTM -68.74%
Return on equity TTM -151.27%
Profit margin 0%
Book value 0.007
Market capitalisation $39.5 million

TTM: trailing 12 months

ResApp Health share dividends

We're not expecting ResApp Health to pay a dividend over the next 12 months.

Have ResApp Health's shares ever split?

ResApp Health's shares were split on a 3:8 basis on 28 May 2015. So if you had owned 8 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your ResApp Health shares – just the quantity. However, indirectly, the new 166.7% higher share price could have impacted the market appetite for ResApp Health shares which in turn could have impacted ResApp Health's share price.

ResApp Health share price volatility

Over the last 12 months, ResApp Health's shares have ranged in value from as little as $0.046 up to $0.19. A popular way to gauge a stock's volatility is its "beta".

RAP.AU volatility(beta: 0.54)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while ResApp Health's is 0.5395. This would suggest that ResApp Health's shares are less volatile than average (for this exchange).

ResApp Health overview

ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company offers ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department, and primary care markets; and SleepCheck, a direct-to-consumer smartphone application for the self-assessment of sleep apnoea in 36 countries. Its technology uses sound to diagnose respiratory diseases, including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease, and asthma. ResApp Health Limited has a joint development and pilot agreement with Medgate AG to integrate and test smartphone-based acute respiratory diagnostic test. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was founded in 2014 and is headquartered in Brisbane, Australia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform